SCHEMBL8153192

SCHEMBL8153192

CCc1nc2cc(Nc3nccc(-c4ccc(N5CCN(C(=O)OCc6ccccc6)CC5)nc4)n3)ccc2o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 2/20 0.46
▸ ZAP70 P43403 6/20 0.45
▸ RAB9A P51151 2/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ CCNT1 O60563 2/20 0.41
▸ CDK9 P50750 2/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ DGAT1 O75907 2/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ EGFR P00533 1/20 0.41
▸ PRKCG P05129 1/20 0.41
▸ PRKCB P05771 1/20 0.41
▸ LCK P06239 1/20 0.41
▸ PRKCA P17252 1/20 0.41
▸ PRKCH P24723 1/20 0.41
▸ PRKCI P41743 1/20 0.41
▸ PRKCE Q02156 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8145178 0.83 HDAC1 (0.46) BRAFZAP70HDAC1CCNT1CDK9
SCHEMBL8154100 0.83 ZAP70 (0.61) BRAFZAP70CCNT1CDK9PRKD3
SCHEMBL8139918 0.82 SYK (0.46) BRAFZAP70HDAC1CCNT1CDK9
SCHEMBL8149363 0.81 ZAP70 (0.59) ZAP70CCNT1CDK9PRKD3EGFR
SCHEMBL8148529 0.80 BRAF (0.45) BRAFZAP70RAB9AHDAC1NPC1
SCHEMBL8148183 0.74 HDAC1 (0.53) RAB9AHDAC1NPC1DGAT1KDM4E
SCHEMBL8146572 0.73 HDAC1 (0.48) BRAFZAP70RAB9AHDAC1DGAT1
SCHEMBL8148560 0.69 ZAP70 (0.48) BRAFZAP70CCNT1CDK9CCNA2
SCHEMBL13705283 0.69 NPC1 (0.44) RAB9ANPC1GRIN2B
SCHEMBL8148420 0.69 WNT3A (0.49) ZAP70CCNT1CDK9CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6093716-A Substituted 2-pyrimidineamines and processes for their preparation CELLTECH THERAPEUTICS, LIMITED (GB) 2000-07-25 — — US disclosed
EP-0929549-A1 SUBSTITUTED 2-PYRIMIDINEAMINES, THEIR PREPARATION AND THEIR USE AS PROTEINE KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1999-07-21 — — EP disclosed
WO-1998011095-A1 SUBSTITUTED 2-PYRIMIDINEAMINES, THEIR PREPARATION AND THEIR USE AS PROTEINE KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-03-19 — — WO disclosed
Send feedback